SCHEMBL5879501

SCHEMBL5879501

c1ccc(NCCC2CCNC2)nc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.44
CXCR4 P61073 1/20 0.41
FABP1 P07148 1/20 0.41
FABP6 P51161 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.40
BRD4 O60885 1/20 0.40
ADORA2B P29275 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
HTR1A P08908 1/20 0.39
HTR1D P28221 1/20 0.39
CCNT1 O60563 1/20 0.39
KDM1A O60341 2/20 0.38
MAOB P27338 2/20 0.38
MAOA P21397 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5879518 0.91 CYP1A2 (0.47) CYP1A2CYP2C19CXCR4FABP1FABP6
SCHEMBL5798269 0.79 CYP1A2 (0.50) CYP1A2CYP2C19CXCR4FABP1FABP6
SCHEMBL4720018 0.79 HRH4 (0.51) CYP1A2CXCR4FABP1FABP6IRAK4
SCHEMBL4522025 0.75 CXCR4 (0.49) CYP1A2CYP2C19CXCR4FABP1FABP6
Hydrochloric Acid SCHEMBL21641198 0.74 CXCR4 (0.47) CYP1A2CYP2C19CXCR4FABP1FABP6
Hydrochloric Acid SCHEMBL30585800 0.74 CXCR4 (0.47) CYP1A2CYP2C19CXCR4FABP1FABP6
SCHEMBL3265804 0.72 CYP1A2 (0.70) CYP1A2CYP2C19CXCR4FABP1FABP6
SCHEMBL25422820 0.71 IRAK4 (0.50) IRAK4
SCHEMBL13326544 0.71 IRAK4 (0.50) IRAK4
SCHEMBL18973376 0.71 SLC6A4 (0.45) SLC6A2SLC6A4SLC6A3KDM1AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105508-B1 Integrin receptors antagonists ABBOTT GMBH & CO. KG (DE) 2006-09-12 US disclosed
CN-1374960-A novel integrin receptor antagonists BASF AG (DE) 2002-10-16 CN disclosed
EP-1202988-A2 NOVEL INTEGRIN RECEPTOR ANTAGONISTS BASF AKTIENGESELLSCHAFT (DE) 2002-05-08 EP disclosed
WO-2001010847-A2 NOVEL INTEGRIN RECEPTOR ANTAGONISTS BASF AKTIENGESELLSCHAFT (DE) 2001-02-15 WO disclosed